Monsanto Company (NYSE:MON) – Stock analysts at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of Monsanto in a research note issued on Wednesday. Jefferies Group analyst L. Alexander forecasts that the basic materials company will earn $3.29 per share for the quarter. Jefferies Group has a “Hold” rating and a $128.00 price target on the stock. Jefferies Group also issued estimates for Monsanto’s FY2019 earnings at $6.65 EPS and FY2020 earnings at $7.35 EPS.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period last year, the firm posted $0.07 EPS. Monsanto’s revenue for the quarter was up 4.8% on a year-over-year basis. ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/05/monsanto-company-mon-forecasted-to-earn-q2-2018-earnings-of-3-29-per-share.html.

Several other equities analysts have also commented on MON. BMO Capital Markets restated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Thursday. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 price target (up previously from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Finally, Barclays PLC upped their price target on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Thursday, June 29th. Ten research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $125.33.

Shares of Monsanto (NYSE:MON) traded up 0.17% on Thursday, reaching $119.41. 542,612 shares of the company’s stock traded hands. The company has a 50 day moving average of $118.11 and a 200-day moving average of $116.97. The stock has a market capitalization of $52.46 billion, a PE ratio of 25.79 and a beta of 1.07. Monsanto has a 52 week low of $97.35 and a 52 week high of $120.50. Monsanto also was the recipient of some unusual options trading activity on Wednesday. Stock traders acquired 63,484 put options on the stock. This represents an increase of approximately 1,793% compared to the typical volume of 3,354 put options.

A number of hedge funds and other institutional investors have recently modified their holdings of MON. Parkwood LLC lifted its holdings in Monsanto by 61.0% in the 1st quarter. Parkwood LLC now owns 6,130 shares of the basic materials company’s stock valued at $694,000 after acquiring an additional 2,323 shares during the last quarter. YorkBridge Wealth Partners LLC lifted its holdings in Monsanto by 33.6% in the 1st quarter. YorkBridge Wealth Partners LLC now owns 1,534 shares of the basic materials company’s stock valued at $179,000 after acquiring an additional 386 shares during the last quarter. Wedbush Securities Inc. lifted its holdings in Monsanto by 0.9% in the 1st quarter. Wedbush Securities Inc. now owns 4,671 shares of the basic materials company’s stock valued at $529,000 after acquiring an additional 42 shares during the last quarter. Engineers Gate Manager LP acquired a new stake in Monsanto in the 1st quarter valued at about $1,034,000. Finally, CI Investments Inc. lifted its holdings in Monsanto by 308.2% in the 1st quarter. CI Investments Inc. now owns 33,870 shares of the basic materials company’s stock valued at $3,834,000 after acquiring an additional 25,572 shares during the last quarter. 74.81% of the stock is owned by institutional investors.

In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the company’s stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The disclosure for this sale can be found here. Insiders sold a total of 77,910 shares of company stock valued at $9,242,439 in the last quarter. 0.79% of the stock is currently owned by insiders.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.80%. Monsanto’s dividend payout ratio is presently 46.75%.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Earnings History and Estimates for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.